Clinical Trials | PRECEDE - Pancreatic Cancer Early Detection Consortium

The University of Virginia Comprehensive Cancer Center seeks adults ages 18 and over with risk of pancreatic ductal adenocarcinoma (PDAC) for a research study. The purpose of this research study is to collect clinical information, family history, and biosamples from individuals and families at risk for pancreatic cancer. This study will take place across many clinical sites as part of the Pancreatic Cancer Early Detection (PRECEDE) Consortium. Collecting this information and samples will create a resource to drive research necessary for early detection and prevention of PDAC. You may be eligible for this study if: - You have one family member with pancreatic cancer and a known pathogenic germline variant - Two or more of your family members have PDAC - You have a history of PDAC - You have a pancreas cyst - You have a pathogenic or likely pathogenic germline variant in a gene linked to PDAC - You are willing to donate samples for discovery studies The study involves a baseline visit and up to 2 visits per year, depending on the frequency of your clinical care pancreas cancer screening. The visits will include laboratory tests and procedures such as having your blood drawn and collecting biosamples, reviewing your medical history, and reviewing your medicals records to access results from your routine clinical care such as genetic testing, imaging studies (e.g., MRI/MRCP, endoscopic ultrasound, CT abdomen). Study-related procedures, such as collection of research biosamples, will be provided at no cost. Additional information can be found here: https://clinicaltrials.gov/study/NCT04970056 [email protected]